These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 22476595

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Proton-pump inhibitors can decrease gastrointestinal bleeding after percutaneous coronary intervention.
    Jiang Z, Wu H, Duan Z, Wang Z, Hu K, Ye F, Zhang Z.
    Clin Res Hepatol Gastroenterol; 2013 Dec; 37(6):636-41. PubMed ID: 23684576
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
    Hsiao FY, Tsai YW, Huang WF, Wen YW, Chen PF, Chang PY, Kuo KN.
    Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
    [Abstract] [Full Text] [Related]

  • 8. Upper gastrointestinal bleeding in patients receiving dual antiplatelet therapy after coronary stenting.
    Yasuda H, Yamada M, Sawada S, Endo Y, Inoue K, Asano F, Takeyama Y, Yoshiba M.
    Intern Med; 2009 Sep; 48(19):1725-30. PubMed ID: 19797827
    [Abstract] [Full Text] [Related]

  • 9. Proton pump inhibitors and other disease-based factors in the recurrence of adverse cardiovascular events following percutaneous coronary angiography: A long-term cohort.
    Ayub A, Parkash O, Naeem B, Murtaza D, Khan AH, Jafri W, Hamid S.
    Indian J Gastroenterol; 2016 Mar; 35(2):117-22. PubMed ID: 27056735
    [Abstract] [Full Text] [Related]

  • 10. [Does dual antiplatelet therapy always require gastroprotection? Tailored medical therapy should prevail over the generalized prescription of proton pump inhibitors in patients on dual antiplatelet therapy].
    Marcucci R.
    G Ital Cardiol (Rome); 2010 Jun; 11(6):481-7; discussion 487. PubMed ID: 20922874
    [No Abstract] [Full Text] [Related]

  • 11. [The incidence, clinical characteristics and risk factors of upper gastrointestinal bleeding in patients taking dual antiplatelet therapy after percutaneous coronary intervention in south China].
    Zhang ZF, Sha WH, Tan GY, Wang QY.
    Zhonghua Nei Ke Za Zhi; 2016 Jun; 55(6):445-50. PubMed ID: 27256606
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and Safety of Proton-Pump Inhibitors in High-Risk Cardiovascular Subsets of the COGENT Trial.
    Vaduganathan M, Cannon CP, Cryer BL, Liu Y, Hsieh WH, Doros G, Cohen M, Lanas A, Schnitzer TJ, Shook TL, Lapuerta P, Goldsmith MA, Laine L, Bhatt DL, COGENT Investigators.
    Am J Med; 2016 Sep; 129(9):1002-5. PubMed ID: 27143321
    [Abstract] [Full Text] [Related]

  • 13. Trends in cardiovascular and bleeding outcomes in acute coronary syndrome patients treated with or without proton-pump inhibitors during the introduction of novel P2Y12 inhibitors: a five-year experience from a single-centre observational registry.
    Hoedemaker NPG, Damman P, Ottervanger JP, Dambrink JHE, Gosselink ATM, Kedhi E, Kolkman E, de Winter RJ, van 't Hof AWJ.
    Eur Heart J Cardiovasc Pharmacother; 2019 Jul 01; 5(3):127-138. PubMed ID: 30084902
    [Abstract] [Full Text] [Related]

  • 14. PPI use in patients commenced on clopidogrel: a retrospective cross-sectional evaluation.
    Luinstra M, Naunton M, Peterson GM, Bereznicki L.
    J Clin Pharm Ther; 2010 Apr 01; 35(2):213-7. PubMed ID: 20456741
    [Abstract] [Full Text] [Related]

  • 15. Effects of proton pump inhibitors on adverse gastrointestinal events in patients receiving clopidogrel: systematic review and meta-analysis.
    Kwok CS, Nijjar RS, Loke YK.
    Drug Saf; 2011 Jan 01; 34(1):47-57. PubMed ID: 21047145
    [Abstract] [Full Text] [Related]

  • 16. The prevalence of co-administration of clopidogrel and proton pump inhibitors.
    Shrestha K, Hughes JD, Lee YP, Parsons R.
    Qual Prim Care; 2011 Jan 01; 19(1):35-42. PubMed ID: 21703110
    [Abstract] [Full Text] [Related]

  • 17. Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from the BASKET trial.
    Burkard T, Kaiser CA, Brunner-La Rocca H, Osswald S, Pfisterer ME, Jeger RV, BASKET Investigators.
    J Intern Med; 2012 Mar 01; 271(3):257-63. PubMed ID: 21726302
    [Abstract] [Full Text] [Related]

  • 18. Proton pump inhibitors and clopidogrel - hazardous drug interaction or hazardous interpretation of data?
    Moayyedi P, Sadowski DC.
    Can J Gastroenterol; 2009 Apr 01; 23(4):251-2. PubMed ID: 19373416
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clopidogrel with or without omeprazole in coronary artery disease.
    Bhatt DL, Cryer BL, Contant CF, Cohen M, Lanas A, Schnitzer TJ, Shook TL, Lapuerta P, Goldsmith MA, Laine L, Scirica BM, Murphy SA, Cannon CP, COGENT Investigators.
    N Engl J Med; 2010 Nov 11; 363(20):1909-17. PubMed ID: 20925534
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.